Related Experiment Video
Updated: May 7, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Breakthrough Vaccines and Transformative Therapies on the Horizon of Progress toward Diabetes Management
Dewesh Kumar1, Shashi Bhushan Singh2, Vidya Sagar3
1Associate Professor, Department of Community Medicine, RIMS, Ranchi, Jharkhand, India.
Background:
Diabetes mellitus, affects millions of people globally. Over the years, diabetes has emerged as a significant global health concern, with steadily increasing prevalence.
Objectives:
This review explores the various aspects of diabetes mellitus, and delves into the evolving field of new emerging treatments and diabetes vaccines, highlighting the potential they hold in revolutionizing diabetes management in the future.
Materials And Methods:
Literature search was done in PubMed database and relevant articles were selected for the narrative review.
Results:
The review reveals that currently most vaccines that have been developed are in animal studies and early phases of trials. Only few human trials have been conducted, but, with positive outcome. There are also some novel therapeutics emerging as potential management options for diabetes. Therefore, it is imperative to know about the potential vaccines and novel emerging treatment options for diabetes mellitus, to understand the challenges faced in constructing novel vaccines and the intricate relationship between diabetes and Alzheimer's disease, an emerging entity as Type 3 Diabetes.
Conclusion:
There is a growing interest in the development of vaccines as a revolutionary approach to diabetes management. As our understanding of diabetes deepens and vaccine technology advances, the prospect of a diabetes vaccine becoming a reality offers hope for millions living with this condition and in reducing the burden of diabetes-related complications.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Microorganisms in Medicine and Therapeutics
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Type II Diabetes I: Introduction

